California Cancer Reporting System Standards Volume I: Abstracting and Coding Procedures
This appendix includes the current Screening List of ICD-10-CM Codes for Casefinding as well as links to historical lists.
Certain ICD-10-CM* codes used by medical records departments for discharge diagnoses identify cases of malignant neoplasms that are reportable to the California Cancer Registry. Case finding procedures must include the review of medical records coded with the following numbers. Newly reportable diseases are followed by the ICD-O-3 morphology and behavior code in parentheses.
REPORTABLE NEOPLASMS |
|
ICD-10-CM Code |
Explanation of ICD-10-CM Code |
C00.- - C43.-, C4A.-, C45.- - C96.- |
Malignant neoplasms (excluding category C44), stated or presumed to be primary (of specified site) and certain specified histologies New for FY2017: C49.A-, Gastrointestinal Stromal Tumors, Effective 10/1/2016 |
C44.00, C44.09 |
Unspecified/other malignant neoplasm of skin of lip |
C44.10-, C44.19- |
Unspecified/other malignant neoplasm of skin of eyelid |
C44.20-, C44.29- |
Unspecified/other malignant neoplasm skin of ear and external auricular canal |
C44.30-, C44.39- |
Unspecified/other malignant neoplasm of skin of other/unspecified parts of face |
C44.40, C44.49 |
Unspecified/other malignant neoplasm of skin of scalp & neck |
C44.50-, C44.59- |
Unspecified/other malignant neoplasm of skin of trunk |
C44.60-, C44.69- |
Unspecified/other malignant neoplasm of skin of upper limb, incl. shoulder |
C44.70-, C44.79- |
Unspecified/other malignant neoplasm of skin of lower limb, including hip |
C44.80, C44.89 |
Unspecified/other malignant neoplasm of skin of overlapping sites of skin |
C44.90, C44.99 |
Unspecified/other malignant neoplasm of skin of unspecified sites of skin |
D00.- - D09.- |
In-situ
neoplasms |
D18.02 |
Hemangioma of intracranial structures and any site |
D32.- |
Benign neoplasm of meninges (cerebral, spinal and unspecified) |
D33.- |
Benign neoplasm of brain and other parts of central nervous system |
D35.2 - D35.4 |
Benign neoplasm of pituitary gland, craniopharyngeal duct and pineal gland |
D42.-, D43.- |
Neoplasm of uncertain or unknown behavior of meninges, brain, CNS |
D44.3 - D44.5 |
Neoplasm of uncertain or unknown behavior of pituitary gland, craniopharyngeal duct and pineal gland |
D45 |
Polycythemia
vera (9950/3) |
D46.- |
Myelodysplastic syndromes (9980, 9982, 9983, 9985, 9986, 9989, 9991, 9992) |
D47.1 |
Chronic
myeloproliferative disease (9963/3, 9975/3)
|
D47.3 |
Essential
(hemorrhagic) thrombocythemia (9962/3) |
D47.4 |
Osteomyelofibrosis
(9961/3)
|
D47.Z- |
Neoplasm of uncertain behavior of lymphoid, hematopoietic and related tissue, unspecified (9960/3, 9970/1, 9971/3, 9931/3) |
D47.9 |
Neoplasm of uncertain behavior of lymphoid, hematopoietic and related tissue, unspecified (9970/1, 9931/3) |
D49.6, D49.7 |
Neoplasm of unspecified behavior of brain, endocrine glands and other CNS |
R85.614 |
Cytologic evidence of malignancy on smear of anus |
R87.614 |
Cytologic evidence of malignancy on smear of cervix |
R87.624 |
Cytologic evidence of malignancy on smear of vagina |
*Note: Pilocytic/juvenile astrocytoma M-9421 moved from behavior /3 (malignant) to /1 (borderline malignancy) in ICD-O-3. However, SEER registries will CONTINUE to report these cases and code behavior as /3 (malignant)
Note: Cases with the codes listed below should be screened as registry time allows. Experience in the SEER registries has shown that using the supplemental list increases casefinding for benign brain and CNS, hematopoietic neoplasms, and other reportable diseases.
SUPPLEMENTAL CODES |
|
ICD-10-CM Code |
Explanation of ICD-10-CM Code |
B20 |
Human immunodeficiency virus [HIV] disease with other diseases |
B97.33, B97.34, B97.35 |
Human T-cell lymphotrophic virus,( type I [HTLV-1], type II [HTLV-II], type 2 [HIV 2]) as the cause of diseases classified elsewhere |
B97.7 |
Papillomarvirus as the cause of diseases classified elsewhere |
C44.01, C44.02 |
Basal/squamous cell carcinoma of skin of lip |
C44.11-, C44.12- |
Basal/squamous cell carcinoma of skin of eyelid |
C44.21-, C44.22- |
Basal/squamous cell carcinoma of skin of ear and external auricular canal |
C44.31-, C44.32- |
Basal/squamous cell carcinoma of skin of other and unspecified parts of face |
C44.41, C44.42 |
Basal/squamous cell carcinoma of skin of scalp and neck |
C44.51-, C44.52- |
Basal/squamous cell carcinoma of skin of trunk |
C44.61-, C44.62- |
Basal/squamous cell carcinoma of skin of upper limb, including shoulder |
C44.71-, C44.72- |
Basal/squamous cell carcinoma of skin of lower limb, including hip |
C44.81, C44.82 |
Basal/squamous cell carcinoma of skin of overlapping sites of skin |
C44.91, C44.92 |
Basal/squamous cell carcinoma of skin of unspecified sites of skin |
D10.- - D31.-, D34, D35.0, D35.1, D35.5- |
Benign neoplasms (see "must collect" list for reportable benign neoplasms) Note: Screen for incorrectly coded malignancies or reportable by agreement tumors |
D35.9, D36.- |
Note: Borderline cystadenomas M-8442, 8451, 8462, 8472, 8473, of the ovaries moved from behavior /3 (malignant) to /1 (borderline malignancy) in ICD-O-3. SEER registries are not required to collect these cases for diagnoses made 1/1/2001 and after. However, cases diagnosed prior to 1/1/2001 should still be abstracted and reported to SEER. |
D3A._ |
Benign carcinoid tumors |
D37._ - D41._ |
Neoplasms
of uncertain or unknown behavior (see "must collect"
list for reportable neoplasms of uncertain or unknown behavior) |
D44.0 - D44.2, |
Neoplasm
of uncertain or unknown behavior of other endocrine glands (see
"must collect" list for D44.3-D44.5) |
D47.0 |
Histiocytic
and mast cell tumors of uncertain behavior |
D47.2 |
Monoclonal
gammopathy |
D47.Z2 |
Castleman disease |
D48.- |
Neoplasm of uncertain behavior of other and unspecified sites |
D49.0 - D49.9 |
Neoplasm of unspecified behavior (except for D49.6 and D49.7) |
D61.1 |
Drug-induced
aplastic anemia (also known as “aplastic anemia due to antineoplastic
chemotherapy”) |
D61.810 |
Antineoplastic chemotherapy induced pancytopenia |
D61.82 |
Myelophthisis |
D63.0 |
Anemia
in neoplastic disease |
D64.81 |
Anemia due to antineoplastic chemotherapy |
D69.49, D69.59, D69.6 |
Other
thrombocytopenia |
D70.1 |
Agranulocytosis
secondary to cancer chemotherapy |
D72.1 |
Eosinophilia (Note: Code for eosinophilia (9964/3). Not every case of eosinophilia is a malignancy. Reportable Diagnosis is "Hypereosonophilic syndrome.") |
D75.81 |
Myelofibrosis
(note: this is not primary myelofibrosis [9961/3] |
D76.- |
Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue |
D89.0, D89.1 |
Other
disorders involving the immune mechanism, not elsewhere classified |
D89.4 |
Mast cell activation syndrome and related disorders Note: Effective 10/1/2016 |
E08 |
Diabetes
mellitus due to underlying condition |
E31.2- |
Multiple
endocrine neoplasia [MEN] syndromes |
E34.0 |
Carcinoid
syndrome |
E83.52 |
Hypercalcemia |
E88.09 |
Other disorders of plasma-protein metabolism, not elsewhere classified |
E88.3 |
Tumor lysis syndrome (following antineoplastic chemotherapy) |
G13.0 |
Paraneoplastic
neuromyopathy and neuropathy |
G13.1 |
Other
systemic atrophy primarily affecting central nervous system in
neoplastic disease |
C32.8- |
Other
specified degenerative disorders of nervous system in diseases
classified elsewhere |
G53 |
Cranial
nerve disorders in diseases classified elsewhere |
G55 |
Nerve
root and plexus compressions in diseases classified elsewhere |
G63 |
Polyneuropathy
in diseases classified elsewhere |
G73.1 |
Lambert-Eaton
syndrome in neoplastic disease |
G89.3 |
Neoplasm related pain (acute)(chronic) |
G99.2 |
Myelopathy
in diseases classified elsewhere |
H47.42 |
Disorders
of optic chiasm in (due to) neoplasm |
H47.52- |
Disorders
of visual pathways in (due to) neoplasm |
H47.63- |
Disorders
of visual cortex in (due to) neoplasm |
J34.81 |
Nasal mucositis (ulcerative) |
J91.0 |
Malignant
pleural effusion |
J93.12 |
Secondary
spontaneous pneumothorax
|
K12.31 |
Oral mucositis (ulcerative) due to antineoplastic therapy |
K12.33 |
Oral mucositis (ulcerative) due to radiation |
K22.711 |
Barrett's esophagus with high grade dysplasia |
K62.7 |
Radiation proctitis |
K62.82 |
Dysplasia of anus (AIN I and AIN II) |
K92.81 |
Gastrointestinal mucositis (ulcerated) (due to antineoplastic therapy) |
M36.0 |
Dermato(poly)myositis
in neoplastic disease |
M36.1 |
Arthropathy
in neoplastic disease
|
M84.5- |
Pathologic
fracture in neoplastic disease |
M90.6- |
Osteitis
deformans in neoplastic disease |
N42.3 |
Dysplasia of prostate (PIN I and PIN II) |
N76.81 |
Mucositis (ulcerative) of vagina and vulva |
N87.- |
Dysplasia of cervix uteri (CIN I and CIN II) |
N89.0, N89.1, N89.3 |
Vaginal dysplasia (VIN I and VIN II) |
N90.0, N90.1, N90.3 |
Vulvar dysplasia (VAIN I and VAIN II) |
O01.- |
Hydatidiform
mole |
O9A.1- |
Malignant
neoplasm complicating pregnancy, childbirth and the puerperium
(conditions in C00-C96) |
Q85.0- |
Neurofibromatosis
(nonmalignant) (9540/1) |
R18.0 |
Malignant
ascites
|
R53.0 |
Neoplastic
(malignant) related fatigue |
R59.- |
Enlarged lymph nodes |
R85.6- |
Abnormal
findings on cytological and histological examination of digestive
organs |
R87.61-, R87.62- |
Abnormal
findings on cytological/histological examination of female genital
organs |
R92.- |
Abnormal findings on diagnostic imaging of breast |
R97.- |
Abnormal tumor markers |
T38.6- |
Poisoning by antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified |
T38.8-, T38.9- |
Poisoning by hormones and their synthetic substitutes |
T45.1- |
Poisoning by, adverse effect of and under dosing of antineoplastic and immunosuppressive drugs |
T45.8-, T45.9- |
Poisoning by primary systemic and hematological agent, unspecified |
T66 |
Unspecified effects of radiation |
T80.1 |
Vascular complications following infusion, transfusion and therapeutic injection |
T80.2- |
Infections following infusion, transfusion and therapeutic injection |
T80.810 |
Extravasation of vesicant antineoplastic chemotherapy |
T80.818 |
Extravasation of other vesicant agent |
T86.0 |
Complications
of bone marrow transplant |
Y63.2 |
Overdose of radiation given during therapy |
Y84.2 |
Radiological procedure and radiotherapy as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure |
Z03.89 |
Encounter for observation for other suspected diseases and conditions ruled out |
Z08 |
Encounter
for follow-up examination after completed treatment for malignant
neoplasm (medical surveillance following completed treatment) |
Z12.- |
Encounter for screening for malignant neoplasms |
Z13.0 |
Encounter for screening for diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism |
Z15.0 |
Genetic
susceptibility to malignant neoplasm |
Z17.0, Z17.1 |
Estrogen
receptor positive and negative status |
Z40.0- |
Encounter for prophylactic surgery for risk factors related to malignant neoplasms |
Z42.1 |
Encounter for breast reconstruction following mastectomy |
Z48.3 |
Aftercare
following surgery for neoplasm |
Z48.290 |
Encounter for aftercare following bone marrow transplant |
Z51.0 |
Encounter for antineoplastic radiation therapy |
Z51.1- |
Encounter for antineoplastic chemotherapy and immunotherapy |
Z51.5, Z51.89 |
Encounter for palliative care and other specified aftercare |
Z79.81- |
Long
term (current) use of agents affecting estrogen receptors and
estrogen levels |
Z80.- |
Family history of primary malignant neoplasm |
Z85.- |
Personal
history of malignant neoplasm |
Z86.0-, Z86.01-, Z86.03 |
Personal history of in situ and benign neoplasms and neoplasms of uncertain behavior |
Z92.21, Z92.23, Z92.25. Z92.3 |
Personal history of antineoplastic chemotherapy, estrogen therapy, immunosuppression therapy or irradiation (radiation) |
Z94.81, Z94.84 |
Bone marrow and stem cell transplant status |
^International Classification of Diseases, ICD-10-CM Tabular List of Diseases and Injuries, FY 2017
Historical Codes for Casefinding ICD-10-CM, Jan 1 through Dec 31, 2016
Historical Codes for Casefinding ICD-9-CM, Jan 1 through Dec 31, 2015
Historical Codes for Casefinding ICD-9-CM, Jan 1 through Dec 31, 2014
Historical Codes for Casefinding ICD-9-CM, Jan 1 through Dec 31, 2013
Historical Codes for Casefinding ICD-9-CM, Jan 1 through Dec 31, 2012
Historical Codes for Casefinding ICD-9-CM, Jan 1 through Dec 31, 2011
Historical Codes for Casefinding ICD-9-CM, Jan 1 through Dec 31, 2010
Historical Codes for Casefinding ICD-9-CM, Jan 1 through Dec 31, 2009
Historical Codes for Casefinding ICD-9-CM, Jan 1 through Dec 31, 2008